Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.99
Surgery Partners, Inc. reported for fiscal year 2023 results: revenue greater than $2.75 billion. Guidance raised.
- Period
- for fiscal year 2023
- Revenue
- greater than $2.75 billion
- Guidance
- raised
- Result
- guidance update
Exact text from the filing
Full year Adjusted EBITDA guidance raised to greater than $435 million, revenue reaffirmed at greater than $2.75 billion, inclusive of the cyber event, and free cash flow reaffirmed at greater than $140 million.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.99
Surgery Partners, Inc. reported for the second quarter ended June 30, 2023 results: revenue Revenues were $667.6 million, net income Net income attributable to Surgery Partners was $18.9 million.
- Period
- for the second quarter ended June 30, 2023
- Revenue
- Revenues were $667.6 million
- Net income
- Net income attributable to Surgery Partners was $18.9 million
- Result
- reported results
Exact text from the filing
Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced financial results for the second quarter ended June 30, 2023. • Revenues were $667.6 million representing 8.5% growth and are inclusive of an $8 million cyber event headwind • Same-facility revenues increased 8.3% on an unadjusted basis and approximately 10% adjusting for the cyber event • Non-consolidated minority interest revenue increased by over 30% • Net income attributable to Surgery Partners was $18.9 million • Adjusted EBITDA was $100.2 million, representing 16.4% growth • Adjusted EBITDA margin improved by over 100 basis points year-over-year to 15.0% • Combined, consolidated and unconsolidated surgical case volume grew 5%
View on SEC.gov